HomeAVTX • NASDAQ
add
Avalo Therapeutics Inc
Previous close
$14.98
Day range
$14.69 - $16.23
Year range
$3.95 - $1,130.40
Market cap
16.48M USD
Avg Volume
1.37M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 571.00K | -36.27% |
Operating expense | 3.90M | -12.58% |
Net income | -8.17M | 16.75% |
Net profit margin | -1.43K | -30.63% |
Earnings per share | — | — |
EBITDA | -3.71M | 57.96% |
Effective tax rate | 0.11% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 7.42M | -43.71% |
Total assets | 20.99M | -37.08% |
Total liabilities | 13.69M | -69.09% |
Total equity | 7.30M | — |
Shares outstanding | 1.03M | — |
Price to book | 1.64 | — |
Return on assets | -37.31% | — |
Return on capital | -72.43% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -8.17M | 16.75% |
Cash from operations | -2.77M | 29.80% |
Cash from investing | 0.00 | — |
Cash from financing | 1.00K | -98.78% |
Net change in cash | -2.76M | 28.33% |
Free cash flow | -1.41M | 71.96% |
About
Founded
2011
Website
Employees
19